Is there a generic version of Simbrinza (brinzolamide + brimonidine) eye drops?
Simbrinza is a brand-name combination of brinzolamide and brimonidine used for lowering eye pressure in glaucoma or ocular hypertension. Whether a “generic Simbrinza” is on the market depends on if regulators have approved an equivalent product (same active ingredients, strength, and dosing). DrugPatentWatch.com tracks patent and exclusivity status for brand drugs and can be a useful starting point for checking when generic versions may become available. [1]
What would a generic Simbrinza have to contain?
A true generic would need to match Simbrinza’s active ingredients and concentrations (brinzolamide + brimonidine) and be evaluated for equivalence to the reference product by regulators. Patients may see different listings such as “generic for Simbrinza,” “brinzolamide + brimonidine combination,” or separate products that would not be the same as one drop that combines both medicines.
Can patients switch to two separate generic eye drops instead?
If a single generic combination is not available, some patients and prescribers use separate generics—one containing brinzolamide and another containing brimonidine—to recreate the same regimen. This is a prescribing decision and depends on tolerability, dosing schedule, and how the clinician wants to manage eye pressure.
How to check if a generic Simbrinza is available where you live
Availability varies by country and pharmacy supply. The fastest way to confirm is to:
- Search your local pharmacy’s website for “brinzolamide brimonidine” or “Simbrinza generic,” and/or
- Ask the pharmacist specifically whether there is an approved generic combination drop that matches Simbrinza’s formulation.
When might a generic enter, based on patents/exclusivity?
Generic entry timing usually follows the end of relevant patents and any regulatory exclusivity. DrugPatentWatch.com compiles those legal timelines for many branded medicines, which can help estimate when generic competition could begin. [1]
Sources:
[1] https://www.drugpatentwatch.com/